Developer docs
API playgroundTry for free, no card

Search company profiles

InNeuroCo

Full company profile

uuid0004eew

Namestring
InNeuroCo
Legal namestring
InNeuroCo, Inc.
Websiteurl
inneuroco.com
Company typeenum
Private
Founded yearint
2014
Short descriptiontext

InNeuroCo was a private Pembroke Pines, Florida medical device company founded in 2014 that specialized in neurovascular catheter design and production, and was acquired by Integer Holdings Corporation for $44.5 million in October 2023.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPembroke Pines, United States
HQ citystring
Pembroke Pines
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
neurovascular catheters, medical devices, catheter design, neurointerventional devices, minimally invasive devices
Industry1 code
PRIMARYHLAHAKAE
Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories)
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Neurovascular Medical Devices
Social media profiles1 record
Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

InNeuroCo was a neurovascular medical device company that designed and produced catheters used in challenging neurointerventional procedures. The company focused on catheter engineering and manufacturing capabilities for accessing and treating complex neurovascular anatomy. Its assets were acquired by Integer Holdings Corporation in October 2023 for $44.5 million, integrating those catheter design and production capabilities into Integer's medical device portfolio.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Neurovascular Catheters
CategoryNeurovascular Medical Devices
Description

Catheters engineered for use in challenging neurointerventional procedures, designed to navigate complex neurovascular anatomy; intended for hospitals and clinical centers performing neurointerventional surgery.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Peers10 records
TypeBroad incumbent
Description

Medtronic's neurovascular business (historically built on the Covidien/ev3 pipeline of access, aspiration, and delivery catheters for stroke) competes with InNeuroCo across the same neurovascular catheter procedures and represents a major incumbent acquirer/competitor in the space.

2MIVI Neuroscience
TypeEmerging player
Description

MIVI Neuroscience develops neurovascular access and aspiration catheters for stroke treatment; as a smaller, emergent neurovascular catheter developer it is comparable to InNeuroCo's profile in stage and category.

TypeDirect peer
Description

Wallaby Medical is a neurovascular-focused company offering catheter-based and stent-retriever products for stroke intervention; its product scope and clinical focus closely mirror InNeuroCo's neurovascular catheter positioning.

TypeBroad incumbent
Description

Stryker's neurovascular division (built largely through acquisitions of Concentric and Surpass) offers a broad portfolio of neurovascular access and delivery catheters; as a large diversified medtech incumbent it overlapped with InNeuroCo's specialty catheter focus, and was a natural strategic benchmark.

TypeDirect peer
Description

Phenox develops and markets neurovascular catheters, stents, and coil-assisted devices used in stroke and aneurysm procedures; as a focused neurovascular specialist, it is a direct comparable to InNeuroCo's catheter design activity.

TypeBroad incumbent
Description

Cerenovus is J&J's neurovascular arm offering a broad suite of catheters, coils, and access products for stroke and aneurysm treatment; it is a meaningful incumbent with overlapping neurovascular catheter capabilities to InNeuroCo.

TypeDirect peer
Description

Acandis is a German specialist in neurovascular devices including access and delivery catheters for treating ischemic and hemorrhagic stroke; it is a direct small-cap peer in the same niche InNeuroCo targeted.

TypeDirect peer
Description

Penumbra is a leading specialist in neurovascular catheters and aspiration/embolization systems for stroke treatment; it directly competes with InNeuroCo in the neurovascular catheter category and served as a benchmark specialty player in the same market.

TypeOthers
Description

Integer Holdings is the strategic acquirer of InNeuroCo's assets and a contract medical device manufacturer with growing neurovascular capability; it is best characterized as an enabling/strategic ecosystem participant relative to InNeuroCo's specific catheter IP.

10MicroPort NeuroTech
TypeRegional player
Description

MicroPort's neurovascular business offers catheter-based products for cerebrovascular intervention in Asia and other markets; it is a regional neurovascular catheter peer with overlapping therapeutic focus to InNeuroCo.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

InNeuroCo

Neurovascular Medical Devicesinneuroco.com

InNeuroCo was a private Pembroke Pines, Florida medical device company founded in 2014 that specialized in neurovascular catheter design and production, and was acquired by Integer Holdings Corporation for $44.5 million in October 2023.

InNeuroCo firmographics

Firmographics
Name
InNeuroCo
Legal name
InNeuroCo, Inc.
Website
https://inneuroco.com
Company type
Private
Founded year
2014
Operating status
Acquired
Headcount range
11–50 employees
Short description
InNeuroCo was a private Pembroke Pines, Florida medical device company founded in 2014 that specialized in neurovascular catheter design and production, and was acquired by Integer Holdings Corporation for $44.5 million in October 2023.
Ownership category
akta.pro rank

InNeuroCo industry classification

Industry
Product category
Neurovascular Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAKAE
Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories)

Keywords

  • Neurovascular catheters
  • Medical devices
  • Catheter design
  • Neurointerventional devices
  • Minimally invasive devices

Where InNeuroCo is headquartered

Location

Headquarters

HQ city
Pembroke Pines
HQ country
United States
HQ region
North America

Markets served

InNeuroCo business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

InNeuroCo product offering

Product offering

Core offering

InNeuroCo was a neurovascular medical device company that designed and produced catheters used in challenging neurointerventional procedures. The company focused on catheter engineering and manufacturing capabilities for accessing and treating complex neurovascular anatomy. Its assets were acquired by Integer Holdings Corporation in October 2023 for $44.5 million, integrating those catheter design and production capabilities into Integer's medical device portfolio.

Differentiator

Problem solved

Functional benefit

Products and services

  • Neurovascular Catheters Catheters engineered for use in challenging neurointerventional procedures, designed to navigate complex neurovascular anatomy; intended for hospitals and clinical centers performing neurointerventional surgery.

Companies that use InNeuroCo

Customer profile

Ideal customer profiles1 record

InNeuroCo technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

InNeuroCo partnerships and signals

Strategic signal

Scale indicators1 record

InNeuroCo competitors and assessment

Company assessment

Broad incumbents

  • Medtronic Neurovascular: Medtronic's neurovascular business (historically built on the Covidien/ev3 pipeline of access, aspiration, and delivery catheters for stroke) competes with InNeuroCo across the same neurovascular catheter procedures and represents a major incumbent acquirer/competitor in the space.
  • Stryker (Neurovascular): Stryker's neurovascular division (built largely through acquisitions of Concentric and Surpass) offers a broad portfolio of neurovascular access and delivery catheters; as a large diversified medtech incumbent it overlapped with InNeuroCo's specialty catheter focus, and was a natural strategic benchmark.
  • Cerenovus (Johnson & Johnson): Cerenovus is J&J's neurovascular arm offering a broad suite of catheters, coils, and access products for stroke and aneurysm treatment; it is a meaningful incumbent with overlapping neurovascular catheter capabilities to InNeuroCo.

Emerging players

  • MIVI Neuroscience: MIVI Neuroscience develops neurovascular access and aspiration catheters for stroke treatment; as a smaller, emergent neurovascular catheter developer it is comparable to InNeuroCo's profile in stage and category.

Direct peers

  • Wallaby Medical: Wallaby Medical is a neurovascular-focused company offering catheter-based and stent-retriever products for stroke intervention; its product scope and clinical focus closely mirror InNeuroCo's neurovascular catheter positioning.
  • Phenox: Phenox develops and markets neurovascular catheters, stents, and coil-assisted devices used in stroke and aneurysm procedures; as a focused neurovascular specialist, it is a direct comparable to InNeuroCo's catheter design activity.
  • Acandis: Acandis is a German specialist in neurovascular devices including access and delivery catheters for treating ischemic and hemorrhagic stroke; it is a direct small-cap peer in the same niche InNeuroCo targeted.
  • Penumbra: Penumbra is a leading specialist in neurovascular catheters and aspiration/embolization systems for stroke treatment; it directly competes with InNeuroCo in the neurovascular catheter category and served as a benchmark specialty player in the same market.

Others

  • Integer Holdings Corporation: Integer Holdings is the strategic acquirer of InNeuroCo's assets and a contract medical device manufacturer with growing neurovascular capability; it is best characterized as an enabling/strategic ecosystem participant relative to InNeuroCo's specific catheter IP.

Regional players

  • MicroPort NeuroTech: MicroPort's neurovascular business offers catheter-based products for cerebrovascular intervention in Asia and other markets; it is a regional neurovascular catheter peer with overlapping therapeutic focus to InNeuroCo.

Market position

Customer concentration

InNeuroCo social profiles

Digital presence

InNeuroCo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

InNeuroCo leadership team

Management profile

Number of profiles

Profiles2 records

InNeuroCo funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

InNeuroCo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InNeuroCo

What does InNeuroCo do?

InNeuroCo was a neurovascular medical device company that designed and produced catheters used in challenging neurointerventional procedures. The company focused on catheter engineering and manufacturing capabilities for accessing and treating complex neurovascular anatomy. Its assets were acquired by Integer Holdings Corporation in October 2023 for $44.5 million, integrating those catheter design and production capabilities into Integer's medical device portfolio.

Is InNeuroCo a public or private company?

InNeuroCo is a private company. It is classified as corporate owned and is currently acquired.

When was InNeuroCo founded?

InNeuroCo was founded in 2014. It employs 11 to 50 people.

Where is InNeuroCo based?

InNeuroCo is headquartered in Pembroke Pines, United States, in the North America region.

Who are InNeuroCo's main competitors?

Broad incumbents on record are Medtronic Neurovascular, Stryker (Neurovascular) and Cerenovus (Johnson & Johnson). MIVI Neuroscience is listed as an emerging player. Direct peers are Wallaby Medical, Phenox, Acandis and Penumbra. Integer Holdings Corporation is listed as an others. MicroPort NeuroTech is listed as a regional player.

Does InNeuroCo have an API?

No public API is recorded for InNeuroCo.

What industry is InNeuroCo in?

InNeuroCo's product category is Neurovascular Medical Devices. Its primary akta.pro industry code is HLAHAKAE, Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comMarket Segmentation, Major Trends, and Competitive Analysis of the Neurovascular Catheters MarketThe global neurovascular catheters market is projected to reach $8.17 billion by 2030, growing at a compound annual growth rate of 11.0%, driven by increasing cerebrovascular disease cases, aging population, and demand for minimally invasive treatments. In October 2023, Integer Holdings Corporation acquired most of the assets of InNeuroCo, Inc. for $44.5 million to enhance its neurovascular catheter design and production capabilities. Additionally, Q'Apel Medical Inc. secured CE Mark approval in March 2023 for its Walrus Balloon Guide Catheter, a next-generation device designed to improve procedural support during stroke interventions.GlobeNewswireInteger to Showcase Recently Acquired Capabilities and New Technologies at MD&M West 2024Integer Holdings will exhibit at MD&M West 2024 in Anaheim, showcasing its medical device manufacturing capabilities and recent acquisitions of InNeuroCo and Pulse Technologies. The exhibit highlights neurovascular solutions, precision micro machining, and product areas including cardiac rhythm management and cardiovascular solutions.SecEdgarFilingInteger Holdings Corporation reported strong third-quarter 2023 financial results, with sales increasing 18% to $405 million and GAAP net income rising 70% to $27 million. The company simultaneously raised its full-year 2023 outlook for both sales and operating income growth, driven by strong demand in its medical device manufacturing segments. Additionally, Integer completed the acquisition of InNeuroCo assets on October 1, 2023, to expand its neurovascular catheter capabilities.